Embody vs SnagRx (2026): Which Affordable GLP-1 Program Is Actually Cheaper?
By Charly P. · Published August 11, 2026 · 8 min read
Put the two price cards side by side and they look identical: compounded semaglutide at $69/month, compounded tirzepatide at $119/month, no insurance, no membership fee, fast free shipping. Comparison pages that stop there are useless, because the number is the one thing these two agree on. The decision lives in the fine print — what you have to promise to get $69, how much each platform will tell you about who fills your prescription, and what happens if the medication does not work for you. That is what this page is about.
The short answer
Month to month, Embody is cheaper. Embody's $69 semaglutide and $119 tirzepatide carry no long-term commitment. SnagRx's equivalent no-commitment rates are $99 and $149 — its $69/$119 headline is the 12-month plan price.
Over a full year, SnagRx gives you more for the same money. Commit to twelve months and the prices match — at which point SnagRx adds a rate locked at every dose, four named 503A pharmacies, a named clinician network, a stated LegitScript certification, a refund if you are declined and a six-month weight-loss guarantee.
First GLP-1 course? Start flexible. Been on one before and know you tolerate it? The annual plan is the better buy.
Embody vs SnagRx at a Glance
| Factor | Embody | SnagRx |
|---|---|---|
| Compounded Semaglutide | $69/mo, no commitment (list $299) | $69/mo on 12-month plan · $99/mo monthly |
| Compounded Tirzepatide | $119/mo, no commitment | $119/mo on 12-month plan · $149/mo monthly |
| 12-Month Cost (semaglutide) | $828 | $828 annual plan · $1,188 monthly |
| Membership Fee | None | None |
| Price at Higher Doses | One monthly rate; may vary slightly by dose | Locked flat at every dose, for life |
| Clinician Review | Typically within 24 hours | Typically within 5 hours, always within 24 |
| Shipping | Free, 1–2 days after approval | Free next-day UPS/FedEx, temperature-controlled |
| Pharmacy Disclosure | Own network of licensed US pharmacies (unnamed) | Four named US 503A pharmacies, with addresses |
| Prescribing Network | Licensed clinicians, reviewed online | OpenLoop Health, 48 states |
| Compliance Credential | Not advertised | States LegitScript certification |
| Support Model | 24/7 access for dosing and side effects | Patient portal + 1:1 nursing staff |
| Guarantees | None advertised — no commitment instead | Refund if declined; 6-month weight-loss guarantee (terms apply) |
| Insurance | No — cash pay | No — cash pay |
| Other Programs | NAD+, sermorelin, ED on the same platform | GLP-1 weight loss only |
Pricing: The $69 Is Not the Same $69
Both platforms advertise semaglutide at $69 and tirzepatide at $119 against struck-through list prices of $299 and $399. The difference is what sits behind the number. Embody bills month to month with no minimum term — $69 is simply what you pay, and you can stop after any month. SnagRx reaches $69 on its 12-month plan; its month-to-month rate is $99. Same for the dual agonist: $119 annually committed, $149 monthly.
| Scenario | Embody | SnagRx |
|---|---|---|
| 3 months, semaglutide, no commitment | $207 | $297 (Embody −$90) |
| 12 months, semaglutide, committed | $828 | $828 (level) |
| 12 months, semaglutide, staying flexible | $828 | $1,188 (Embody −$360) |
| 3 months, tirzepatide, no commitment | $357 | $447 (Embody −$90) |
| 12 months, tirzepatide, committed | $1,428 | $1,428 (level) |
| Stopping early on a 12-month plan | No penalty — no plan to leave | Governed by the annual plan terms |
Read that table as a question about your own confidence rather than about the providers. If you have taken a GLP-1 before, tolerated it and intend to stay on it for a year, the annual plan costs you nothing extra and SnagRx's price lock protects the rate through the whole titration — semaglutide climbs from 0.25 mg to 2.4 mg, and that is precisely the stretch where per-milligram pricing elsewhere in the market quietly doubles a bill. If this is your first course, the $30/month you save by committing is a bad trade against the chance you stop in week six because of nausea. Both are defensible; only one is right for you.
Approval and Delivery Speed
Embody advertises clinician review typically within 24 hours and free delivery in 1–2 days after approval. SnagRx advertises a five-minute intake, clinician review typically inside five hours and always within 24, then next-day UPS or FedEx in discreet, temperature-controlled packaging. On stated timelines SnagRx has the edge at the approval step and matches or beats Embody at the shipping step.
In practice the gap is smaller than the marketing suggests. Both are fast by the standards of this category, and the variable that most often decides when the box actually lands is you — how quickly you finish the intake and respond if the clinician asks a follow-up. Treat both figures as shipping windows rather than door-to-door guarantees, particularly for cold-chain deliveries over a weekend.
Who Prescribes It and Who Fills It
This is where the two genuinely diverge, and it is the least glamorous section on the page for a reason: it is the part most comparison articles skip.
SnagRx names its chain. Medical care is delivered by OpenLoop Health, a network of US-licensed clinicians across 48 states. Prescriptions are filled by four named 503A compounding pharmacies with published addresses — RedRock Pharmacy (UT), Health Warehouse (KY), Precision Compounding Pharmacy (NY) and Triad Rx (AL). SnagRx also states it holds LegitScript certification, which you can confirm in the LegitScript directory rather than taking a badge on trust.
Embody does not name a public pharmacy partner, describing instead its own network of licensed US compounding pharmacies — which is the more common practice in compounded GLP-1 telehealth and not, on its own, a red flag. It simply leaves you less to verify. If you want to know where your medication is made, it is a reasonable question to put to any provider during intake; SnagRx has already answered it, and a provider that will not answer deserves more scrutiny than one that will.
Be precise about what that disclosure does and does not buy you. A 503A pharmacy is licensed and inspected by its state board of pharmacy; it is not registered with the FDA as an outsourcing facility, which is the separate 503B category. So a named pharmacy is not federal verification — it is simply something you can look up, which is more than an unnamed network gives you. And as the FDA states on its semaglutide page, the compounded medication itself is not FDA-approved and has not been evaluated for safety, efficacy or quality the way Wegovy and Ozempic have. That applies equally to both platforms here.
What Happens If It Does Not Work Out
The two platforms protect you against different failures, which is a cleaner way to think about it than asking which guarantee is “better.”
SnagRx buys down outcome risk. A declined prescription is refunded in full, and it advertises a weight-loss guarantee: six months of treatment without significant weight loss can be refunded, with terms applying. Read those terms before you rely on them — guarantees of this shape usually require documented adherence and a claim inside a specific window, and a guarantee is only as good as the conditions attached.
Embody buys down commitment risk. There is no results guarantee, but there is also nothing to escape: no contract, no minimum term, cancel after any month. For a patient whose main fear is being stuck, that structural freedom is worth more than a conditional refund.
Pros and Cons, Side by Side
Embody — Pros
- ✓$69 semaglutide and $119 tirzepatide with no long-term commitment
- ✓Cheapest of the two for anyone not signing a 12-month plan
- ✓Free shipping in 1–2 days after approval
- ✓24/7 support access for dosing and side-effect questions
- ✓Same platform also runs NAD+, sermorelin and ED programmes
Embody — Cons
- ✗Does not name its compounding pharmacy partners publicly
- ✗No advertised results guarantee
- ✗Notes final pricing may vary slightly by dose and clinician recommendation
- ✗No coaching or nutrition programming
SnagRx — Pros
- ✓Price locked flat at every dose for the life of treatment
- ✓Names four US 503A partner pharmacies and its clinician network (OpenLoop Health)
- ✓States LegitScript certification — independently checkable
- ✓Clinician review typically within 5 hours; next-day temperature-controlled shipping
- ✓Full refund if declined, plus a 6-month weight-loss guarantee (terms apply)
SnagRx — Cons
- ✗The $69/$119 headline rates require the 12-month plan; monthly is $99/$149
- ✗Countdown-timer urgency marketing on the pricing page
- ✗Discloses that some site content may be AI-generated and testimonial imagery may use models
- ✗Weight-loss guarantee carries terms that must be read before relying on it
- ✗GLP-1 weight loss only — no other treatment categories
Who Should Choose Which
Choose Embody if this is your first GLP-1 course, if you want the lowest possible price without signing anything, or if you expect to reassess in a few months. Its $69 is unconditional, which is the whole argument in its favour and a strong one. It also suits readers already using the platform for NAD+ therapy who would rather keep one clinician relationship than open a second.
Choose SnagRx if you are confident you will stay on treatment for a year and want that rate guaranteed through every titration step, or if verifiable disclosure matters to you — the named pharmacies, the named clinician network and the LegitScript claim are things you can check before paying, which is rare at this price. Its outcome guarantees are the closest thing to a safety net either platform offers.
Choose neither if you need branded, FDA-approved medication billed through insurance, or if you know you need structured coaching to stay consistent — in which case a bundled programme that keeps you adherent beats a cheaper vial you stop using. Both of those readers are better served by the ranked list in our best weight loss treatments guide, or by a flat-price alternative such as Refills at $99/mo.
Embody vs SnagRx: Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
The Verdict
Our Editorial Take
There is no winner here that applies to everyone, and any page telling you otherwise is picking for its own reasons rather than yours. The split is clean: Embody is the cheaper way to start, because $69 costs you no promises. SnagRx is the better twelve-month home, because at the same annual price it adds a locked rate, a chain of custody you can verify and refunds attached to outcomes. Match the plan to your confidence in staying on treatment and you will have chosen correctly either way.
Both dispense compounded medication that is not FDA-approved as a finished product, and neither bills insurance. That is the trade the entire $69 tier is built on — worth understanding before you weigh anything else on this page.
Read the full write-ups: Embody GLP-1 review · SnagRx review · all weight loss providers.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.